CSS
TARS icon

Cubist Systematic Strategies’s Tarsus Pharmaceuticals TARS Stock Holding History

Cubist Systematic Strategies’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.4M Buy
+73,955
New +$3.64M 0.02% 1038
2024
Q2 		– Sell
-37,853
Closed -$1.38M – 3980
2024
Q1 		$1.38M Buy
37,853
+34,221
+942% +$1.01M 0.01% 1909
2023
Q4 		$73.5K Buy
+3,632
New +$60.6K ﹤0.01% 3229
2022
Q3 		– Sell
-13,669
Closed -$200K – 4714
2022
Q2 		$200K Buy
+13,669
New +$205K ﹤0.01% 3704

Other funds holding TARS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Cubist Systematic Strategies's TARS Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Tarsus Pharmaceuticals (TARS) in Q3 2025: 73,955 shares worth $4.4M. The stake represents 0.02% of the portfolio and ranks #1038 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in TARS as recently as Q1 2024.

Cubist Systematic Strategies first reported a position in TARS in Q2 2022 and has held it in 4 quarters since. 220 funds tracked by Wall St. Rank hold TARS as of Q3 2025.

  • Cubist Systematic Strategies held 73,955 shares of Tarsus Pharmaceuticals worth $4.4M as of Q3 2025.
  • Tarsus Pharmaceuticals was a new Cubist Systematic Strategies position in Q3 2025.
  • Tarsus Pharmaceuticals made up 0.02% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1038 holding.
  • Cubist Systematic Strategies first reported a position in Tarsus Pharmaceuticals in Q2 2022 and has held it in 4 quarters since.
  • 220 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.